Identification of New Serum Markers for Detection of Abuse With Erythropoietin
|ClinicalTrials.gov Identifier: NCT01320449|
Recruitment Status : Completed
First Posted : March 22, 2011
Last Update Posted : August 1, 2012
University of Aarhus
Information provided by (Responsible Party):
Birgitte Nellemann, University of Aarhus
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||July 2012|
|Actual Study Completion Date :||July 2012|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Nielsen J, Christensen AE, Nellemann B, Christensen B. Lipid droplet size and location in human skeletal muscle fibers are associated with insulin sensitivity. Am J Physiol Endocrinol Metab. 2017 Dec 1;313(6):E721-E730. doi: 10.1152/ajpendo.00062.2017. Epub 2017 Jul 25.
Christensen B, Ludvigsen M, Nellemann B, Kopchick JJ, Honoré B, Jørgensen JO. Serum proteomic changes after randomized prolonged erythropoietin treatment and/or endurance training: detection of novel biomarkers. PLoS One. 2015 Feb 13;10(2):e0117119. doi: 10.1371/journal.pone.0117119. eCollection 2015.